JPRN-UMIN000001129已完成2 期
Gemcitabine versus gemcitabine-carboplatin for elderly patients with advanced non-small cell lung cancer : a prospective randomized phase II study of the Niigata Lung Cancer Treatment Group - Gemcitabine versus gemcitabine-carboplatin for elderly patients with advanced non-small cell lung cancer : a prospective randomized phase II study of the Niigata Lung Cancer Treatment Group
iigata Lung Cancer Treatment Group0 个研究点目标入组 60 人开始时间: 2008年5月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 70years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients were excluded if they had any active concomitant malignancies, symptomatic brain metastases, past history of severe allergic reactions to drugs, interstitial pneumonia identified by chest X-ray, superior vena cava syndrome, or other serious complications, such as uncontrolled angina pectoris, myocardial infarction within 3 months, heart failure, uncontrolled diabetes mellitus or hypertension, uncontrolled massive pleural effusion or ascites.
研究者
相似试验
招募中
4 期
choice between paclitaxel or carboplatin in cisplatin ineligible advanced urinary bladder cancerCTRI/2020/02/023402ALL INDIA INSTITUTE OF MEDICAL SCIENCES RISHIKESH
尚未招募
不适用
Phase I study of gemcitabine and carboplatin plus sorafenib in patients with advanced solid tumorsadvanced solid tumors10027655CancerNL-OMON31053Antoni van Leeuwenhoek Ziekenhuis28
已完成
2 期
The efficacy and safety of gemcitabine / cisplatin combination therapy in patients with advanced refractory biliary tract cancerAdvanced biliary tract cancer refractory to gemcitabine and S-1JPRN-UMIN000001615Faculty of Medicine, University of Tokyo20
已完成
不适用
A randomised study of Gemcitabine with Carboplatin versus Mitomycin, Vinblastine and Cisplatin (MVP) or Mitomycin C, Ifosfamide and Cisplatin (MIC) chemotherapy in inoperable advanced stage non-small cell lung cancer (NSCLC)Cancer: Non small cell lung cancerMalignant neoplasm of bronchus and lungCancerISRCTN41486350Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)372
进行中（未招募）
1 期
ew treatment option for refractory testicular cancer.Refractory histologically confirmed extracranial primary germ cell cancer, seminoma, or nonseminoma germ cell tumoursEUCTR2016-000171-24-SKárodný onkologický ústav43